PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.34%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would suspect a firm-specific problem if peers maintain profit growth.
13.90%
D&A growth of 13.90% while Healthcare median is zero at 0.00%. Walter Schloss would question intangible or new expansions driving that cost difference.
311.60%
Deferred tax growth of 311.60% while Healthcare median is zero at 0.00%. Walter Schloss would see a difference that might matter for future cash flow if significant.
107.88%
SBC growth of 107.88% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or staff additions causing more equity grants.
-42.22%
Working capital is shrinking yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if sales remain robust.
-110.24%
AR shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage in working capital if sales do not drop.
-90.14%
Inventory shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see a working capital edge if sales hold up.
88.89%
AP growth of 88.89% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or credit policies affecting the difference.
224.56%
Growth of 224.56% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or unusual one-time factors behind the difference.
-38.45%
Other non-cash items dropping yoy while Healthcare median is 0.00%. Seth Klarman would see a short-term advantage if real fundamentals remain intact.
-73.67%
Negative CFO growth while Healthcare median is -3.56%. Seth Klarman would suspect a firm-specific operational weakness if peers maintain growth.
-2.03%
CapEx declines yoy while Healthcare median is 0.00%. Seth Klarman would note a short-term FCF advantage if revenue is stable.
-736193.53%
Acquisition spending declines yoy while Healthcare median is 0.00%. Seth Klarman would note reduced M&A risk if growth continues organically.
-100.00%
Investment purchases shrink yoy while Healthcare median is 0.00%. Seth Klarman would see a short-term cash advantage if no high-return opportunities are missed.
-90.37%
We liquidate less yoy while Healthcare median is 0.00%. Seth Klarman would see a firm-specific hold strategy unless missed gains exist.
-83.73%
We reduce “other investing” yoy while Healthcare median is 0.00%. Seth Klarman would see a potential advantage in preserving cash if top-line growth is not harmed.
-414.21%
Reduced investing yoy while Healthcare median is 0.00%. Seth Klarman sees potential advantage in near-term liquidity if revenue remains stable.
26.28%
Debt repayment growth of 26.28% while Healthcare median is zero at 0.00%. Walter Schloss wonders if expansions or a shift in capital structure drive that difference.
100.00%
Issuance growth of 100.00% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or acquisitions financed by new shares.
No Data
No Data available this quarter, please select a different quarter.